Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Gregorio Di Franco

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2156-369X; OpenAlex author ID A5074536340, A5113232123. Sources: OpenAlex.

Their work

Papers
17 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2020: 2 papers · 2021: 4 papers · 2022: 1 paper · 2023: 4 papers · 2024: 3 papers · 2025: 2 papers · 2026: 1 paper

Papers 17

  1. Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
  2. Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors. First author DOI 10.1016/j.semcancer.2025.06.001↗
  3. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  4. The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study. Co-author DOI 10.1016/j.suronc.2024.102081↗
  5. Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study. Co-author DOI 10.1093/bjsopen/zrad119↗
  6. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  7. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  8. Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
  9. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  10. Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing. First author DOI 10.3791/63744↗
  11. In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration. Co-author DOI 10.3390/ijms23073775↗
  12. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  13. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  14. Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients. First author DOI 10.3390/cancers13164131↗
  15. Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma. Co-author DOI 10.3748/wjg.v27.i42.7324↗
  16. The occurrence of prion protein in surgically resected pancreatic adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.08.004↗
  17. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine. Co-author DOI 10.3748/wjg.v26.i21.2792↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Luca Morelli · 9 shared papers, 2020–2025 · strength 1.27
  2. Manuel Gentiluomo · 3 shared papers, 2022–2025 · strength 0.49
  3. Vittoria Raffa · 3 shared papers, 2020–2023 · strength 0.45
  4. Alice Usai · 3 shared papers, 2020–2023 · strength 0.45
  5. Matteo Bianchini · 4 shared papers, 2020–2022 · strength 0.42
  6. Niccola Funel · 4 shared papers, 2020–2021 · strength 0.41
  7. Annalisa Comandatore · 2 shared papers, 2024–2025 · strength 0.37
  8. Ingrid Garajová · 2 shared papers, 2024–2025 · strength 0.37
  9. Elisa Giovannetti · 2 shared papers, 2024–2025 · strength 0.37
  10. Fabio Ausania · 2 shared papers, 2023–2025 · strength 0.34
  11. Caterina Vivaldi · 3 shared papers, 2021–2022 · strength 0.33
  12. Francesco Fornai · 3 shared papers, 2020–2022 · strength 0.32
  13. Chiara Corradi · 1 shared paper, 2025 · strength 0.21
  14. Volkan N. Adsay · 1 shared paper, 2025 · strength 0.21
  15. Daniele Campa · 1 shared paper, 2025 · strength 0.21
  16. Enrico Vasile · 2 shared papers, 2020–2021 · strength 0.21
  17. Andrea Spallanzani · 1 shared paper, 2024 · strength 0.16
  18. Francesco Leonardi · 1 shared paper, 2024 · strength 0.16
  19. Lenka N.C. Boyd · 1 shared paper, 2024 · strength 0.16
  20. Rita Balsano · 1 shared paper, 2024 · strength 0.16
  21. Geert Kazemier M · 1 shared paper, 2024 · strength 0.16
  22. Laleh Golkar Melstrom · 1 shared paper, 2023 · strength 0.13
  23. Steven Alan White · 1 shared paper, 2023 · strength 0.13
  24. Riccardo Memeo · 1 shared paper, 2023 · strength 0.13
  25. John B. Martinie · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.